Nationwide survey on the use of eltrombopag in patients with severe aplastic anemia: a report on behalf of the French Reference Center for Aplastic Anemia

Few therapeutic options are available for patients with aplastic anemia who are ineligible for transplantation or refractory to immunosuppressive therapy. Eltrombopag was recently shown to produce trilineage responses in refractory patients. However, the effects of real-life use of this drug remain...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Haematologica
Main Authors: Lengline, Etienne, Drenou, Bernard, Peterlin, Pierre, Tournilhac, Olivier, Abraham, Julie, Berceanu, Ana, Dupriez, Brigitte, Guillerm, Gaelle, Raffoux, Emmanuel, de Fontbrune, Flore Sicre, Ades, Lionel, Balsat, Marie, Chaoui, Driss, Coppo, Paul, Corm, Selim, Leblanc, Thierry, Maillard, Natacha, Terriou, Louis, Socié, Gerard, de Latour, Regis Peffault
Formato: Artigo
Idioma:Inglês
Publicado: Ferrata Storti Foundation 2018
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5792265/
https://ncbi.nlm.nih.gov/pubmed/29170252
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2017.176339
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares